LASIX ONYU (Furosemide) Patent Expiration, LOE Window & CMS Spending

LASIX ONYU (Furosemide) by Sq Innovation: FDA Orange Book core substance LOE 2042-01-10, 0 AB generics, $0 2024 CMS Part D & Medicaid spend, and $475 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorSq Innovation
FDA Application & PathwayN217294 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE Date2042-01-10
Last Listed Patent or Exclusivity Date2042-01-10
Orange Book Patents (*PED Extensions)3 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($475 intro WAC)